Skip to main content

Novartis signals beyond the news: 52+ signals from 7 sources

The latest Novartis signal on this page is from Oct 27, 2026 (Patents): "NOVARTIS AG's patent output is accelerating: 76 grants in the past year, 8 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (15+) and Patents (11).

PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn

Get Novartis' live signals in Claude or ChatGPT, or by API

AskWhat changed at Novartis this week? Use Autobound signals for novartis.com.
Signals
52+
Sources
7
Last 90 days
41
Latest
Oct 27, 2026

Source: Autobound Signal API · 77 signals tracked for Novartis · updated

Other signals · latest 10

Latest Novartis signals by source

52+ signals for Novartis across 7 sources.

  1. Patents · Patent pace

    NOVARTIS AG's patent output is accelerating: 76 grants in the past year, 8 in the past 30 days.

    Over the past year NOVARTIS AG received 76 US patent grants, concentrated in networking / data transmission and health tech / medical informatics; the recent pace (16 in 90 days) is accelerating versus its trailing baseline.

    Grants, 12 months
    76
    Grants, 90 days
    16
    Grants, 30 days
    8
    Pace
    Accelerating

    Google Patents

  2. Patents · Patent grant

    Novartis was granted a patent for compounds targeting coronavirus diseases.

    In October 2026 Novartis patented drug candidates and formulations for treating, managing, or preventing coronavirus-related diseases in clinical and patient-care settings.

    Patent title
    Compounds and compositions for the treatment of coronaviral related diseases
    Grant date
    Oct 27, 2026
    Inventors
    Denghui Bao, Fengfeng Guo, Matthew James Hesse, Viktor Hornak

    Google Patents

  3. Web traffic · Traffic snapshot

    novartis.com received 1M monthly visits with traffic from 5 countries.

    Emerging AI traffic at 1.2% (~14,342 visits). Top: chatgpt.com (85%), gemini.google.com (8%), claude.ai (5%), perplexity.ai (0%).

    Monthly visits
    1,153,193
    Month over month
    +12.9%
    3-month change
    -12.6%
    Global rank
    49,234
  4. Glassdoor · Cross functional collaboration issues

    Novartis has bureaucracy and disconnected efforts hampering collaboration

    Employees describe massive company bureaucracy and scattered efforts across the organization, with a lack of clarity on roles due to constant shifting of groups.

    Overall rating
    4.0 of 5
    CEO approval
    87%
    Reviews read
    10
    Review window
    Oct 1, 2026 to Oct 9, 2026

    Glassdoor

  5. Glassdoor · Compensation dissatisfaction

    Customer service reps report low pay despite high responsibility

    One customer service representative review states there is way too much responsibility for low pay and suggests spreading work out and updating training.

    Overall rating
    4.0 of 5
    CEO approval
    87%
    Reviews read
    10
    Review window
    Oct 1, 2026 to Oct 9, 2026

    Glassdoor

  6. Reddit · Customer feedback

    Novartis is criticized by clinical research professionals for being bureaucratic and having clunky systems.

    Post: "Sponsor & FSP Rankings"

    Subreddit
    r/clinicalresearch
    Upvotes
    40
    Comments
    16
    Sentiment
    Negative

    r/clinicalresearch

  7. Website changes · Funding news

    Novartis added prominent coverage of its second-quarter and first-half 2026 financial results.

    Added homepage feature: “Novartis Financial Results – Q2 2026” and “Novartis announces the company’s financial results for the second quarter and first half of 2026,” with a link to the Q2 2026 results page.

    Page
    /

    novartis.com

  8. Web traffic · Traffic decline

    novartis.com traffic declined 28% to 1M monthly visits.

    Minimal AI traffic at 0.8% (~10,201 visits). Top: chatgpt.com (73%), gemini.google.com (2%), claude.ai (0%).

    Monthly visits
    1,319,655
    Month over month
    -28.5%
    3-month change
    +34.4%
    Global rank
    43,408
  9. Employee growth · Several teams growing

    Rapid growth across 15 departments with Education leading at 44% YoY growth.

    Company is experiencing multi-department expansion, with 15 departments showing significant growth (≥5% YoY). The fastest growing department is Education at 44% growth, adding approximately 451 employees.

    Total headcount
    74,718
    Company growth, 1 year
    +7%
    Median tenure
    6.1 years
  10. LinkedIn

    Celebrating our environmental progress!

    Celebrating our environmental progress! We are proud to be recognized by CDP, an independent non-profit organization enabling environmental disclosures, with double A list status for the fourth consecutive year – achieving the highest possible ‘A’ rating for our work in both climate and water. This recognition...

    Likes
    402
    Comments
    23
    Tags
    Sustainability, Corporate Strategy

    LinkedIn

Showing 10 of 52+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novartis with the Signal API

One POST /v1/companies/enrich call with novartis.com returns Novartis signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "novartis.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Novartis other signals

What signals does Autobound track for Novartis besides news and filings?
This page lists 52+ signals for Novartis from 7 sources: Glassdoor (15+), Website changes (15+), Patents (11), Reddit (4), Web traffic (4), Employee growth (2) and LinkedIn (1). Every row is dated, and most link to the post, review or record.
What are people saying about Novartis online?
The newest posts on this page: Sep 29, 2026, Reddit (r/clinicalresearch): Novartis is criticized by clinical research professionals for being bureaucratic and having clunky systems. Sep 16, 2026, Reddit (r/biotech): Novartis has discontinued its Amyotrophic Lateral Sclerosis (ALS) program following a failure in its phase 2 clinical trial, adding to its R&D challenges. Aug 29, 2026, Reddit (r/FundRaise): A crowdfunding post notes that Novartis is the sole manufacturer of a one-time gene therapy cure for SMA type 2, citing a cost of $2 million USD (16 crore INR).
What do employees say about working at Novartis?
The newest Glassdoor theme on this page, dated Oct 9, 2026: Novartis has bureaucracy and disconnected efforts hampering collaboration. The overall rating in that row is 4.0 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Novartis been granted patents recently?
Yes. The newest grant on this page: Oct 27, 2026, Patents (Google Patents): Novartis was granted a patent for compounds targeting coronavirus diseases.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →